Results 41 to 50 of about 1,482,290 (356)

Decreased Growth with Serotonin Reuptake Inhibitors

open access: yesPediatric Neurology Briefs, 2002
Growth and growth hormone secretion were evaluated in 4 children (3 boys), aged 11.6 to 13.7 years, treated with selective serotonin reuptake inhibitors (SSRIs) for obsessive compulsive disorder or Tourette syndrome, at Schneider Children’s Medical ...
J Gordon Millichap
doaj   +1 more source

IMPACT OF PLANT GROWTH INHIBITORS ON THE GROWTH AND YIELD OF SORGHUM

open access: yesThe Iraqi Journal of Agricultural science, 2021
Field experiment was carried out during the spring and fall seasons of 2019 at the Abu Ghraib Research Station of the Agricultural Research Office/ Ministry of Agriculture, was aimed to investigate the effect of plant growth inhibitors on growth and ...
N. M. Abood, E. M. SHALAL, M. I. HAMDAN
doaj   +1 more source

Influence of Pseudomonas fluorescens x Azospirillum brasilense and Prohexadion-Ca on Poa annua L. growth and spreading in turfgrasses

open access: yesOrnamental Horticulture
This study addresses the challenge of managing Poa annua (annual bluegrass), a problematic weed in turfgrass systems such as athletic fields, golf courses, and ornamental lawns.
Miha Curk   +3 more
doaj   +1 more source

Tyrosine kinase inhibition produces specific alterations in axon guidance in the grasshopper embryo [PDF]

open access: yes, 1998
Tyrosine kinase signaling pathways are essential for process outgrowth and guidance during nervous system development. We have examined the roles of tyrosine kinase activity in programming growth cone guidance decisions in an intact nervous system in ...
Menon, Kaushiki P., Zinn, Kai
core  

Evaluation of the radiosensitizing potency of chemotherapeutic agents in prostate cancer cells [PDF]

open access: yes, 2016
PURPOSE: Despite recent advances in the treatment of metastatic prostate cancer, survival rates are low and treatment options are limited to chemotherapy and hormonal therapy.
Mairs, Robert J., Rae, Colin
core   +2 more sources

Rapid Response to Trametinib Combined With Chemotherapy for Infant BRAF‐Fused Chiasmatic Glioma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Infants, less than 1 year, with chiasmatic gliomas (ICG) present a major therapeutic challenge due to large tumor size, decreased vision, rapid progression, and poor response to vincristine/carboplatin chemotherapy. The majority have a BRAF fusion, which may respond to downstream MEK inhibitors but response time is slow. There are no safety or
Helen Toledano   +7 more
wiley   +1 more source

Juglone and Other Biogenic Quinones Differentially Inhibit Cyanobacterial Growth and Could Be Used to Help Maintain Monospecificity of Microalgae Cultures

open access: yesFermentation
Raceway ponds would allow the sustainable production of algal biomass because of their lower cost. However, for successful cultivation, the target organism needs to prevail despite unavoidable contamination by environmental strains.
Giuseppe Forlani
doaj   +1 more source

Identifying tumor cell growth inhibitors by combinatorial chemistry and zebrafish assays. [PDF]

open access: yesPLoS ONE, 2009
Cyclin-dependent kinases (CDKs) play important roles in regulating cell cycle progression, and altered cell cycles resulting from over-expression or abnormal activation of CDKs observed in many human cancers.
Jing Xiang   +9 more
doaj   +1 more source

DeepPurpose-based drug discovery in chondrosarcoma

open access: yesChinese Journal of Plastic and Reconstructive Surgery, 2022
Background: Chondrosarcoma (CS) is the second most common primary bone tumor, accounting for approximately 30% of all malignant bone tumors. Unfortunately, the efficacy of currently available drug therapies is limited.
Jianrui Li   +3 more
doaj   +1 more source

A PRSZT Registry Analysis of Prognostic Factors Influencing Survival and Relapse Rates After Second Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT A second allogeneic (allo‐)hematopoietic stem cell transplantation (HSCT2) is a potential curative option for pediatric patients with acute lymphoblastic leukemia (ALL) following relapse after first allogeneic transplantation (HSCT1), but its efficacy is limited by high relapse rates and transplant‐related toxicity in highly pretreated ...
Ava Momm   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy